Evaluation of Circulating Tumor Cells and Related Events as Prognostic Factors and Surrogate Biomarkers in Advanced NSCLC Patients Receiving First-Line Systemic Treatment

By Muinelo-Romay Laura   Vieito Maria   Abalo Alicia   Alonso Nocelo Marta   Barón Francisco   Anido Urbano   Brozos Elena   Vázquez Francisca   Aguín Santiago   Abal Miguel   López López Rafael  

Cancers, Vol. 6, Iss. 1, 2014-01 ,pp. : 153-165

MDPI

Access to resources Recommend Favorite

Successful Everolimus Treatment in a Patient with Advanced Pancreatic Neuroendocrine Tumor Who Developed Everolimus-Induced Interstitial Lung Disease on Two Occasions: A Case Report

By  

Chemotherapy, Vol. 59, Iss. 1, 2013-07 ,pp. : 74-78

Karger

Access to resources Recommend Favorite

Treatment of Community-Acquired Pneumonia

By  

Chemotherapy, Vol. 46, Iss. 1, 2000-05 ,pp. : 24-31

Karger

Access to resources Recommend Favorite

Quality of Life in Patients with NSCLC Receiving Maintenance Therapy

By Rittmeyer Achim  

Cancers, Vol. 7, Iss. 2, 2015-05 ,pp. : 950-962

MDPI

Access to resources Recommend Favorite

Gene Mutation Analysis in EGFR Wild Type NSCLC Responsive to Erlotinib: Are There Features to Guide Patient Selection?

By Ulivi Paola   Delmonte Angelo   Chiadini Elisa   Calistri Daniele   Papi Maximilian   Mariotti Marita   Verlicchi Alberto   Ragazzini Angela   Capelli Laura   Gamboni Alessandro   Puccetti Maurizio   Dubini Alessandra   Burgio Marco Angelo   Casanova Claudia   Crinò Lucio   Amadori Dino   Dazzi Claudio  

International Journal of Molecular Sciences, Vol. 16, Iss. 1, 2014-12 ,pp. : 747-757

MDPI

Access to resources Recommend Favorite